SUFU and colorectal cancer: Other mutations of Sufu residing in critical residues for Fbxl17 binding have been described in colorectal cancer and malignant melanoma (Krauthammer et al, 2012; Giannakis et al, 2014); thus, alteration in Fbxl17–Sufu axis could be present in other cancer types.